January 17, 2025

Risks of Preterm Birth, Low Birth Weight, Birth Defects Among Children Born to Young Men With Cancer

Investigators have explored the risk of having children who experience preterm birth, low birth weight, and birth defects among male adolescents and young adults with cancer.

The ASCO Post

January 17, 2025

FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer

Today, the FDA approved a TROP-2–directed antibody and topoisomerase inhibitor conjugate for adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer ...

The ASCO Post

January 17, 2025

FDA Chief Warns of Online Drug Risks

Outgoing FDA Commissioner raises concerns about safety of online-purchased compounded weight loss meds, highlighting challenges faced by the FDA, amidst contrasting views from nominee for Health and Human Services Secretary.

Reuters

January 17, 2025

Trial: High-Dose Semaglutide Cuts Weight 20.7%

Novo Nordisk's high-dose semaglutide trial demonstrates a 20.7% weight reduction in overweight patients with obesity, promising new advancements in the treatment of obesity and diabetes.

Reuters

January 17, 2025

Fulvestrant vs Anastrozole in Endocrine Therapy–Naive, HR-Positive, HER2-Negative Advanced Breast Cancer

The final overall survival analysis of the phase III FALCON trial was recently reported.

The ASCO Post

January 17, 2025

Visa and Mastercard antitrust settlement: What small businesses need to know

Merchants who accepted Visa and Mastercard payments may be entitled to compensation from a class action settlement.

ADA News

January 17, 2025

Patient Care Declines After PE Acquisition

A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.

Conexiant

January 17, 2025

CDC Urges 24-Hour Bird Flu Tests

The CDC emphasizes timely testing for avian influenza A in hospitalized patients to prevent delays and enhance rapid public health responses. Low person-to-person transmission risk has been reported with ongoing U.S. cases among farmworkers.

Reuters

January 17, 2025

FDA Approves Sotorasib With Panitumumab for KRAS G12C–Mutated Colorectal Cancer

On January 16, the FDA approved a KRAS G12C inhibitor in combination with a monoclonal antibody for adult patients with KRAS G12C–mutated metastatic colorectal cancer, as determined by an FDA-approved...

The ASCO Post